GW Pharmaceuticals Hopes to Raise $252 Million in Public Offering
Following the successful trials of its new cannabis-based medication, British drug manufacturer GW Pharmaceuticals announced it will raise $252 million through the issuing of 2.8 million shares on the Nasdaq in…